Related Articles
Pharmacokinetic and pharmacodynamic profiles of subcutaneous administration of continuous erythropoietin receptor activator in lung cancer patients with anemia induced by chemotherapy
SUBCUTANEOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN PREVENTS CHEMOTHERAPY-RELATED ANEMIA IN PATIENTS WITH ADVANCED CANCER
Baseline anemia and anemia grade are independent prognostic factors for stage IV non‑small cell lung cancer
Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer
Optimized pro-active management of anemia by Epoetin α in pre-operative chemotherapy for primary breast cancer